ArticleFrontiers in artificial intelligence2025
Explainable AI-driven MRI-based brain tumor classification: a novel deep learning approach.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Brain Tumor Segmentation and Grading on MRI Using Deep Learning: A Systematic Literature Review and Benchmark-Driven Comparative Analysis.Diagnostics (Basel, Switzerland) · 2026Review
- An Explainable Multi-Scale Deep Learning Framework for Multi-Class Brain MRI Classification.Diagnostics (Basel, Switzerland) · 2026Article
- Multi-Chaotic HEOA for Hardware-Aware Neural Architecture Search: Brain Tumor Classification on FPGA.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Brain tumors are among the most aggressive forms of cancer, requiring precise diagnosis and treatment planning to improve patient outcomes. This study aims to develop an efficient deep learning-based framework for the classification of brain tumors using MRI data. Methods: The methodology employs Convolutional Neural Networks (CNNs) to accurately classify tumors into four categories: normal, glioma, pituitary, and meningioma. Key preprocessing techniques, including noise reduction,resizing, and data augmentation, were applied to enhance the robustness of the model. Advanced architectures such as DenseNet50, VGG19, and other transfer learning models, along with CNN variants, were trained and evaluated for their performance. Explainable AI (XAI) techniques, including Grad-CAM, LIME, and feature map visualizations, played a crucial role in providing better visualizations of the model's decision-making process and identifying areas of improvement during model training and to establish a better model. Results: The best-performing model, a 4-conv-1-dense-1-dropout CNN, achieved a classification accuracy of 95.86%, outperforming deeper architectures and transfer learning approaches. The findings underscore the potential of deep learning models for reliable and efficient brain tumor classification. This work concludes with recommendations for real-time deployment in clinical settings and explores future integration with Large Language Models (LLMs) to generate detailed diagnostic reports.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.